Literature DB >> 20138567

Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B.

Guangying Qi1, Yasusei Kudo, Toshinori Ando, Takaaki Tsunematsu, Natsumi Shimizu, Samadarani B S M Siriwardena, Maki Yoshida, Mohammad Reza Keikhaee, Ikuko Ogawa, Takashi Takata.   

Abstract

Survivin belongs to the inhibitors of apoptosis (IAP) gene family and inhibits apoptosis. Besides its role as IAP, Survivin recently appears to function as a subunit of the chromosomal passenger complex (CPC) for regulating cell division with other CPC proteins including Aurora-B and INCENP. Nuclear Survivin is suspected to control cell division, whereas cytoplasmic Survivin is considered cytoprotective. Although there are several studies on Survivin expression and its function as inhibition of apoptosis, there is no study on Survivin function as a CPC and its correlation with other CPC proteins in head and neck squamous cell carcinoma (HNSCC). Here, therefore, we examined nuclear Survivin expression and its functional correlation with Aurora-B in HNSCC. High expression of Survivin was well correlated with Aurora-B expression in nuclear fraction of HNSCC cell lines and tissues. Moreover, nuclear Survivin expression was significantly correlated with Ki-67 and Aurora-B expression by immunohistochemistry. Notably, HNSCC cases with nuclear Survivin and Aurora-B expression exhibited marked malignant behaviors. Interestingly, both Survivin and Aurora-B knockdown inhibited cell growth and tumorsphere formation. Overall suggest that nuclear Survivin may be involved in tumor progression together with Aurora-B, and that Survivin and Aurora-B can be useful diagnostic markers and therapeutic targets. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138567     DOI: 10.1016/j.oraloncology.2010.01.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

Review 1.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

2.  Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis.

Authors:  Toshihiro Inubushi; Aki Kawazoe; Mutsumi Miyauchi; Yasusei Kudo; Min Ao; Atsushi Ishikado; Taketoshi Makino; Takashi Takata
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

3.  High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer.

Authors:  O P Erpolat; P U Gocun; M Akmansu; E Karakus; G Akyol
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

4.  Expression of survivin, MUC2 and MUC5 in colorectal cancer and their association with clinicopathological characteristics.

Authors:  Haipeng Wang; Shengjian Jin; Huiling Lu; Sisi Mi; Wenhua Shao; Xiaoxv Zuo; Huangyi Yin; Sien Zeng; Fumio Shimamoto; Guangying Qi
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

5.  Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines.

Authors:  Roman C Brands; Mario J J Scheurer; Stefan Hartmann; Axel Seher; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

6.  Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer.

Authors:  Handan Tuncel; Fumio Shimamoto; Hiroshi Kaneko Guangying Qi; Eriko Aoki; Hiroshi Jikihara; Shiro Nakai; Takashi Takata; Masaaki Tatsuka
Journal:  Oncol Lett       Date:  2012-03-06       Impact factor: 2.967

7.  Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.

Authors:  Hiroshi Kitamura; Toshihiko Torigoe; Yoshihiko Hirohashi; Hiroko Asanuma; Ryuta Inoue; Sachiyo Nishida; Toshiaki Tanaka; Naoya Masumori; Noriyuki Sato; Taiji Tsukamoto
Journal:  Virchows Arch       Date:  2012-11-20       Impact factor: 4.064

8.  Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.

Authors:  Ying-Ray Lee; Wei-Ching Wu; Wen-Tsai Ji; Jeff Yi-Fu Chen; Ya-Ping Cheng; Ming-Ko Chiang; Hau-Ren Chen
Journal:  J Biomed Sci       Date:  2012-01-27       Impact factor: 8.410

9.  New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas.

Authors:  Efterpi Kostareli; Dana Holzinger; Jochen Hess
Journal:  Front Oncol       Date:  2012-04-11       Impact factor: 6.244

10.  Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.

Authors:  Annelies W Turksma; Hetty J Bontkes; Janneke J Ruizendaal; Kirsten B J Scholten; Johanneke Akershoek; Shakila Rampersad; Laura M Moesbergen; Saskia A G M Cillessen; Saskia J A M Santegoets; Tanja D de Gruijl; C René Leemans; Chris J L M Meijer; Erik Hooijberg
Journal:  J Transl Med       Date:  2013-06-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.